Clearing Mycotoxins: What the Evidence Shows and What Practice Does
Between the promise of "detoxed in four weeks" and the honest data lies a wide gap. This article walks you through both: what studies really show, and what a cautious step-by-step concept looks like in practice.
"Clearing mycotoxins" sounds like a switch you flip. It is not. It is more the question of how you help your body clear its own excretion pathways again, without overwhelming it in the process.
I write honestly about where the evidence is solid and where it gets thin. And I show you the order I follow myself. It rests on clinical experience and on physiological reasoning, not on studies that tested exactly this order. One thing upfront: I deliberately use the word detox with caution.
How I label evidence in this article
A large part of what is known about mycotoxin effects and their binding comes from in vitro cell studies and animal models. Robust human studies specifically on clearance are limited. I transparently mark the level of evidence for each study.
When the detox cure does the opposite
A pattern I meet again and again in my consultations: someone reads that mold could be behind brain fog and exhaustion, and starts on their own. High doses of activated charcoal, chlorella, plus a harsh "liver detox" from the internet. And it gets worse from week to week instead of better.
What is often overlooked is the environment. Binding happens while new burden is added daily. If digestion is sluggish on top of that, a high binder dose can intensify constipation instead of relieving it.
What comes first in such situations, in my view, sounds unspectacular: first clarify the environment, then back to mini-steps. Digestion, sleep, fluid intake. And if binding happens at all, then very slowly and at a low dose.
Clarification: I am describing a typical picture here, not a concrete case and not a documented course. I claim no causality and no treatment outcome with it. Nothing can be derived from it about what would happen with you. What I want to show is the idea: order before intensity.
First an uncomfortable point: "detox" is a difficult word
You feel something inside that wants to get out. That is an honest feeling. And the industry knows this. "Detox" sells because it serves that feeling. That is why I want to clear things up first, before we talk about tools.
Your body is not a bucket you "rinse out." It has a highly developed system to transform and excrete foreign substances: liver, bile, kidney, gut, lymph, skin. Many mycotoxins are processed via exactly these pathways. The honest question is therefore not "How do I flush poison out?" but "How do I support the pathways my body uses anyway, and how do I stop the resupply?"
Instead of "I have to detox," this sentence is closer to the point: "I take away the burden and support my own excretion." That sounds less dramatic, but it is more honest and safer. Because the fastest "detox protocol" is often the one where the most goes wrong. Caution here is not hesitation, it is strategy.
And now you know why I never use the word "detox" without reservation. It promises control where biology rather needs guidance.
What the evidence supports
Do you sometimes feel lost between forums that promise everything and a body of data that is genuinely thin on this topic? Many people feel that way. It is not down to bad medicine, it is down to how little has been robustly studied here so far. Let us look at what is actually proven and where we have to phrase things carefully.
The solid pillar: binding in the gut for aflatoxins
The most robust evidence for mycotoxin binding comes from aflatoxin research with clay-based binders. Here there are not only animal data, but also a controlled human study.
In a randomized, placebo-controlled phase IIa study, adults in Ghana took a specially prepared clay (NovaSil) before meals over three months. After one month no difference was measurable yet. After three months the aflatoxin markers in blood were lower in both dose groups than under placebo, and the clear reduction in urine of up to 58 percent showed only in the higher dose group. That can support the principle that suitable binders can reduce the uptake of certain mycotoxins in the gut.
On safety: in this study no notable safety problems occurred with the tested preparation over three months, and the values for vitamins A and E, iron and zinc remained unremarkable. That is a statement about one specific preparation, one specific dose and three months. It is not a statement that binders are generally harmless, and certainly not one about use over a year.
Important for context: this is the world of aflatoxins from food. For other mycotoxins, and especially for the indoor-typical burden from water damage, the data is considerably thinner. The principle is plausible, the direct proof in humans is often not there.
The mechanistic pillar: enterohepatic circulation
Some mycotoxins, especially ochratoxin A, are excreted via the bile and partly reabsorbed in the gut. This enterohepatic circulation prolongs their residence time in the body. This is exactly where the idea comes in to bind in the gut and interrupt the circulation.
In an animal model, cholestyramine in the feed was able to attenuate the effect of zearalenone in mice. That is a different mycotoxin from aflatoxin or ochratoxin A, and it is an animal experiment. For ochratoxin A the idea of binding in the gut is mechanistically plausible, because it circulates enterohepatically. It is not proven in humans. Human studies specifically in mold burden are rare, clinical experience reports numerous. More on this in the cholestyramine spoke.
The uncertain pillar: "pushing the detox organs"
Here it gets tricky. That the liver, glutathione and phase 2 metabolism are involved in the processing of mycotoxins is well described, mainly from laboratory and animal models. That a particular supplement scheme can be derived from this, one that measurably clears mycotoxins faster in humans, is not. Much of what is sold as "liver detox" is plausibility, not proof.
Three levels of evidence, three different degrees of certainty. Binding in the gut for aflatoxins: relatively solid. Interruption of the enterohepatic circulation: mechanistically and in animal experiments plausible. Targeted "organ detox": predominantly experiential knowledge, little human evidence. Reputable is whoever does not blur these differences.
This is fair too: the AWMF guideline on mold exposure in indoor environments sees the proven health consequences mainly in the allergic and irritant range, that is allergy, asthma and irritation of the airways, and it takes a reserved view of measuring mycotoxins in urine or blood for routine diagnostics. A widely cited review by Chang and Gershwin even largely disputes the connection between indoor mold and systemic complaints. I see it differently from my practice and I give my reasons here. But you should know that my view is not the prevailing one.
And now you know why I say "can" so often with "clearing." Not out of caution for caution's sake, but because the study situation demands it.
Before you think of mycotoxins: rule out the obvious
Exhaustion and brain fog have many possible causes, and the most common of them are treatable. Before you invest months in a mycotoxin strategy, the obvious belongs ruled out. That includes iron deficiency and anaemia, an underactive thyroid, diabetes, coeliac disease, a vitamin B12 deficiency, reduced kidney function, an unrecognized sleep apnoea and depression.
For mold itself the same applies: best proven are allergy, asthma and irritation of the airways, and with a corresponding pre-existing condition also allergic bronchopulmonary aspergillosis. These routes are diagnostically well accessible and they belong checked first. Take this to your family doctor. Binding for a year while an anaemia or an underactive thyroid stays unrecognized would be the worst of all paths.
Please do not wait a few weeks, but get examined promptly if you lose weight unintentionally, have fever or night sweats, cough up blood, or if new neurological deficits appear such as paralysis, speech or vision disturbances. With acute shortness of breath, chest pain or sudden paralysis, call the emergency number (112 in Germany, 911 in the US), not the practice.
The step-by-step concept: order is the actual therapy
If you take only one thing from this article, then this: With mycotoxins, the order decides more than the individual agent. Those who attack too strongly too early can get worse. Those who stay too cautious make no progress. The following order is my own approach. It rests on clinical experience and on mechanistic reasoning, not on studies that tested exactly this order. I describe it so that you understand why pace and sequence might matter at all, not as a proven scheme. It matches the treatment pyramid in the pillar.
Stop exposure
This is non-negotiable and comes before everything else. As long as you sleep in a burdened apartment or sit at a burdened workplace, resupply arrives daily. Binding against ongoing resupply is working against your own success.
Concretely: go through your living and work history honestly, environmental analysis, if needed a building-biology investigation, remediation or, in case of doubt, relocation. Whoever noticeably flourishes on vacation and collapses again at home has an important clue.
Stabilize digestion and excretion
Before anything is bound, the pathways must be open. Regular bowel movements, sufficient fluids, stable sleep, a low-inflammation diet. In very sensitive people, stabilization of the mucous membranes and mast cells often belongs here too.
The thinking behind it: if gut, liver and kidney are overloaded, it may be that substances are not excreted the way they would need to be. That is a consideration from physiology, not a process proven in humans. What is certain is only this: a sluggish gut and too little fluid are not a good starting point for any form of binding.
Bind mycotoxins carefully
Only now do binders come into consideration. Discussed are activated charcoal, chlorella, bentonite and zeolite as dietary supplement or medical device. The specialist literature also describes cholestyramine, a prescription medication that has no approval for this question. Whether, when and with what anything is bound at all is decided by the treating doctor in the individual case, not by an article and not by a protocol from the internet. If binding happens, then starting low, increased slowly and with a time gap from meals, medications and minerals.
Which binder suits whom is individual. There is no universal protocol that is right for everyone. Details on the individual agents can be found in the linked spokes further down.
Accompany the liver and glutathione metabolism
In parallel and carefully: support the body's own processing. Sleep, nutrition, bitter substances, movement, warmth. Where sensible and medically assessed, targeted support of the glutathione metabolism. Here especially the rule is: low, slow, oriented to tolerability.
In anthroposophic terms the liver is often described as a "warmth and transformation organ." That is an experiential-medicine imagery, not a mechanism proven by large randomized studies. I use it as an image, not as proof.
Guidance, patience and re-evaluation
Mycotoxin-oriented work is a marathon, not a sprint. Observe the course, adjust the pace, rotate or pause binders, reassess regularly. Quick cures are more a warning sign than a seal of quality.
For individual constellations, the literature also discusses antifungal treatment, that is prescription medications against fungi. That is something completely different from a binder. Such agents can strain the liver, affect the heart rhythm and interact with many other medications. They come into question only after a clear indication, with laboratory monitoring and under medical responsibility, not as the next step in a clearance plan. For people with an intact immune system, colonization by indoor mold is, incidentally, not the rule.
The binders at a glance: what they are, how they are classified
Binders are the heart of the clearance idea. It is important to separate cleanly: what is a dietary supplement or medical device, and what is a prescription medication? For most of these agents, use in mycotoxin burden is off-label or beyond the approved intended purpose and belongs in medical care.
Binders do not distinguish between toxin and medication. They can bind anticoagulants such as warfarin or phenprocoumon, thyroid hormones such as levothyroxine, the contraceptive pill, digoxin, antiepileptics and immunosuppressants, and thereby weaken their effect. Chlorella contains a lot of vitamin K and can disturb the setting of anticoagulants.
Folate, iron and the fat-soluble vitamins A, D, E and K can also be bound. In pregnancy and while breastfeeding, in children and adolescents, with reduced kidney function and with liver disease, binders therefore do not belong in self-management. Speak with your doctor beforehand and bring your medication list.
Activated charcoal
The broadest, unspecific binder. Can bind many substances, including minerals, the contraceptive pill and other medications, hence a strict time gap. Constipation is common, and with swallowing difficulties there is a risk of aspiration. For dietary supplements with activated charcoal there is only a single authorised health claim, and it concerns bloating after eating, not mycotoxins.
Chlorella
Freshwater alga, used more as a complement. High starting doses can trigger reactions in sensitive people. Two things that rarely appear alongside: chlorella contains a lot of vitamin K and can disturb the setting of anticoagulants, and the iodine content matters with thyroid disease. Algae products can be contaminated depending on their origin, among other things with microcystins. There is no authorised health claim. More in the chlorella spoke.
Bentonite
Mineral clay. What has been studied is above all a special, prepared clay from aflatoxin research (NovaSil). Those study results cannot simply be transferred to commercially available bentonite, that is a different product. For bentonite as a dietary supplement there is no authorised health claim. Clay products have also repeatedly been objected to over lead and heavy metal content, so only verified quality. More in the bentonite spoke.
Zeolite (clinoptilolite)
Zeolite (clinoptilolite) is an aluminosilicate. Exactly from that follows the most important precaution: it can release aluminium, and with reduced kidney function it therefore does not belong in self-management. What has been studied is above all the binding of smaller molecules. What that means for a mycotoxin burden in everyday life is not proven. Use only certified products and clarify it medically beforehand. More in the zeolite spoke.
Cholestyramine (colestyramine, trade name in Germany for example Quantalan) is a prescription medication, approved for lowering elevated cholesterol levels and for itching due to bile stasis. For a mycotoxin burden there is no approval, any use would be off-label. The thinking behind it: it can bind substances that circulate enterohepatically in the gut.
Important to know if this agent is under discussion: it can cause severe constipation, in extreme cases up to bowel obstruction. It also binds the fat-soluble vitamins A, D, E and K as well as many medications, among them thyroid hormones, anticoagulants, digoxin and the contraceptive pill. Triglycerides can rise. With complete biliary obstruction it must not be given. That is why it belongs in medical hands, with monitoring and with a plan for the vitamin and medication intervals. I deliberately give no dosages here. In detail in the cholestyramine spoke.
If quantity figures appear in the linked spokes, these are expressly illustrative and exemplary for medically guided use. They are not instructions for self-medication. Binders in too high a starting dose can intensify reactions instead of relieving them. The suitable selection, dose and order belongs in an individual medical assessment.
Glutathione and the liver: support instead of overwhelm
Picture glutathione as the main mop your cells use to wipe up what oxidative stress makes. It is the central endogenous antioxidant and is involved in phase 2 detoxification in the liver.
A review summarizes that mold and mycotoxins can act on the nervous system via the immune system, among other routes through messenger substances from mast cells. For several mycotoxins it is also described in cell and animal models that they can trigger oxidative stress. Whether and how strongly a relevant glutathione depletion follows from this in humans is not proven. I name this connection here as a hypothesis, not as an established mechanism.
In practice, support rarely means "one more pill." It means first: enough sleep, in which repair takes place at all. A diet that supplies building blocks instead of additional burden. Movement in a tolerable amount. Only after that, individually and medically assessed, do targeted precursors or supplements come into play.
And now you know why I become suspicious when someone sells "high-dose glutathione" as the first step. Without a foundation it fizzles out or overwhelms.
The PNEI lenses on clearance
Why does one person react to the same strategy quite differently from another? Because clearance is never just chemistry in the gut. Four systems have a say.
1. Nervous system
What I observe in practice, and I deliberately say observe: many people with a long history of burden seem to be in permanent alarm. Whether that shows up in measured values such as vagal tone has not been cleanly studied for this group. In this state the body can tolerate brisk clearance poorly. Calming the nervous system, breath, sleep and safety are not "nice extras," they can be the prerequisite for clearance being tolerated at all.
2. Immune system
Mast cell activation and low-grade inflammation are much discussed in this field, and the connection is contested. A widely cited review largely disputes it for indoor mold. What I observe clinically: those who are immunologically unstable react to binders rather with deterioration. That is why, in my view, stabilization comes before the binding phase in sensitive people. That is a clinical impression, not a body of evidence.
3. Metabolism
Here is the actual metabolic part: mitochondria, glutathione, phase 1 and phase 2 metabolism of the liver. If this engine is exhausted, more mobilization can achieve little and be tolerated worse. First replenish and stabilize, then demand. There are no robust studies on this order, it is a rule of experience.
4. Hormone system
With chronic burden a dysregulated stress axis is often suspected, with an altered cortisol rhythm. That has not been cleanly studied for this group, I am describing a clinical impression. It can influence how much burden a person tolerates. Clearing without regard for the stress axis is like full throttle with the handbrake on.
The most common mistakes when clearing
Mycotoxin clearance is not for self-experiments based on an internet protocol. A strategy without medical guidance can worsen instead of improve, especially in sensitive, long-exhausted people.
- Binding without stopping exposure: You are working against ongoing resupply. The most important step is skipped.
- Starting doses too high: Binders like activated charcoal, chlorella or zeolite in too high a starting dose can trigger severe reactions and constipation.
- "Pushing" clearance without open pathways: If gut, liver and kidney are overloaded, it may be that substances are not excreted the way they would need to be. A sluggish gut and too little fluid are not a good starting point for any form of binding.
- Prescription agents on your own: Cholestyramine is not a dietary supplement. Self-treatment is neither possible nor responsible.
- Ignoring minerals and medications: Binders do not discriminate. Without a time gap and without substitution, deficiencies and loss of effect threaten.
"I do not have to fight. I have to clear the way for my body."
This reframe takes off the pressure. Clearing is not war against your own body, but cleaning up with measure. Whoever understands this stops tormenting themselves with ever harsher cures and begins to work patiently in the right order.
Three levers when you want to start clearing
First clarify the exposure, do not order the supplement
Before you buy a single binder, go through your environment. Water damage, damp rooms, the connection of complaints with places. That is the step with the greatest leverage and costs no powder.
Start small, increase slowly, observe well
If binding happens at all, then in mini-steps. Pace according to tolerability, with a gap from medications and minerals. Better too slow than too fast. Patience here is literally part of the therapy.
Seek medical guidance instead of copying a protocol
Which agents, which dose, which order, that is individual. Look for a doctor who works with environmental medicine questions, who knows your medications and who will also tell you when a path does not make sense. More important than the individual practice is that someone with a medical eye is watching at all, especially with prescription agents.
Frequently asked questions about clearing mycotoxins
Can mycotoxins be cleared at all?
Your body has its own pathways to excrete many mycotoxins via the liver, bile, kidney and gut. Therapeutic approaches try to support these pathways, above all by stopping further intake and by binding in the gut. The data rests mainly on animal and in vitro studies; robust human studies specifically on clearance are limited. The word detox should therefore be used with caution. It makes more sense to speak of supporting the body's own excretion.
What is the most important first step?
Stopping exposure. As long as you continue to live or work in a mold-burdened environment, the tap keeps running while you mop. Environmental analysis, remediation or, if needed, relocation come before any binder or liver strategy. Without this step everything else stays limited.
Which binders are used?
Discussed are activated charcoal, chlorella, bentonite and zeolite as dietary supplements or medical devices. The specialist literature also describes cholestyramine, a prescription medication with no approval for this question. Binders also bind medications and minerals and therefore do not belong in self-treatment. The best data exists for clay-based binders for aflatoxins from animal and individual human studies.
Why is the order so important?
Those who bind too strongly too early can get worse. One consideration behind this is that overloaded excretion pathways may not excrete substances the way they would need to. That is a consideration from physiology, not a process proven in humans. What seems sensible to me is to first stop exposure, then stabilize digestion and excretion, then bind very carefully, then support the liver and glutathione. Patience is part of the therapy.
What role does glutathione play?
Glutathione is the central endogenous antioxidant and is involved in phase 2 detoxification. With ongoing mycotoxin burden the store can be used up faster than it is refilled; this is mainly described in laboratory and animal models. Support can come through precursors, sleep, nutrition and targeted supplementation, individually and assessed medically.
Are mycotoxin tests in urine useful?
Mycotoxin profiles in urine can give a hint, but they are not uncontroversial and not conclusive. Values fluctuate, and a single result does not replace the overall clinical picture from history, environment and symptoms. They can accompany therapy but should not steer it alone.
How long does mycotoxin-oriented therapy take?
This is very individual and often ranges from several months to over a year. The pace depends on tolerability, severity of the burden and the stability of gut, liver and nervous system. Quick cures are more a warning sign than a seal of quality.
Can I not just do this myself with activated charcoal?
This is not advisable. Binders in too high a starting dose can trigger severe reactions, they also bind minerals and medications, and without stopping exposure and stable excretion pathways, self-treatment can do more harm than good. A medically guided, structured approach makes sense.
How do I tell reputable from disreputable clearance?
Look at whether exposure is asked about first, whether the start is slow, whether limits are named and whether the evidence is classified honestly. I would become sceptical with healing promises, with rigid universal protocols for everyone, with very high starting doses and with the word detox as a marketing slogan without reservation.
Related topics
The overview of the cluster: all mycotoxins, all systems, all spokes.
What clinoptilolite can do, what it cannot, and the honest aluminum question.
Why the central antioxidant matters so much with a mycotoxin burden.
Sources and evidence notes
For many statements on mycotoxin clearance the main evidence comes from in vitro cell studies and in vivo animal models. Human studies exist but are limited; best documented is the binding of aflatoxins by clay binders. What is described as biologically plausible is not in every case supported by a large randomized human study. We mark this transparently. Two sources in this list expressly hold a more reserved or opposing position, the AWMF guideline and the review by Chang and Gershwin. They are deliberately included here.
- Wang P et al. NovaSil clay intervention in Ghanaians at high risk for aflatoxicosis: II. Reduction in biomarkers of aflatoxin exposure in blood and urine. Food Addit Contam Part A. 2008;25(5):622-634. doi:10.1080/02652030701598694 [RCT, Human]
- Phillips TD et al. Reducing human exposure to aflatoxin through the use of clay: a review. Food Addit Contam Part A. 2008;25(2):134-145. doi:10.1080/02652030701567467 [Review]
- Underhill KL et al. Effectiveness of cholestyramine in the detoxification of zearalenone as determined in mice. Bull Environ Contam Toxicol. 1995;54(1):128-134. doi:10.1007/BF00196279 [In vivo, animal model, zearalenone]
- Kraljević Pavelić S et al. Critical Review on Zeolite Clinoptilolite Safety and Medical Applications. Front Pharmacol. 2018;9:1350. doi:10.3389/fphar.2018.01350 [Review]
- Ratnaseelan AM et al. Effects of Mycotoxins on Neuropsychiatric Symptoms and Immune Processes. Clinical Therapeutics. 2018. doi:10.1016/j.clinthera.2018.05.004 [Review]
- Chang C, Gershwin ME. The Myth of Mycotoxins and Mold Injury. Clin Rev Allergy Immunol. 2019;57(3):449-455. doi:10.1007/s12016-019-08767-4 [Review, critical counter-position to this article]
- Hope J. A review of the mechanism of injury and treatment approaches for illness resulting from exposure to water-damaged buildings, mold, and mycotoxins. ScientificWorldJournal. 2013. doi:10.1155/2013/767482 [Review, Human]
- Naviaux RK. Metabolic features of the cell danger response. Mitochondrion. 2014. doi:10.1016/j.mito.2013.08.006 [Mechanism review]
- Hurraß J et al. AWMF S2k Guideline 161/001: Medical-clinical diagnostics in mold exposure in indoor environments. AWMF. 2023. register.awmf.org/161-001 [Authority Document, Guideline, takes a reserved view of measuring mycotoxins in body materials]
- Nathan N. Toxic: Heal Your Body from Mold Toxicity. Victory Belt Publishing. 2018. [Review, Practice experience]
As of: 16 June 2026. This post serves general information and does not replace individual medical advice, diagnosis or treatment. Individual substances named are prescription-only or are used off-label; their use belongs exclusively in medical prescription and care. Where anthroposophic or experiential-medicine procedures are mentioned, they rest partly on clinical tradition and are not supported in all respects by large randomized studies. Results are individual and not a guaranteed treatment outcome. Binders and the other agents named here do not belong in self-treatment; speak with your doctor before any use and bring your medication list. With acute symptoms such as shortness of breath, chest pain or sudden paralysis, call the emergency number (112 in Germany, 911 in the US). Author: Shukri Jarmoukli, ViveCura practice, Skalitzer Straße 137, 10999 Berlin.